Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RRBP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | C19orf48 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SLC35B1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | LEPROT | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | KIDINS220 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | UTP4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
mRNA | UPF3B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SNCB | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | SNAP23 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | KIAA1683 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |